<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26311110</article-id><article-id pub-id-type="pmc">4540883</article-id><article-id pub-id-type="publisher-id">jpts-2015-161</article-id><article-id pub-id-type="doi">10.1589/jpts.27.2365</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effects of combined aerobic and resistance training on the glycolipid
metabolism and inflammation levels in type 2 diabetes mellitus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yuan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Sui-xin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cai</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Kang-ling</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wen-liang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Fan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1)</label> Cardiac Rehabilitation Center, Department of
Rehabilitation, Xiangya Hospital, Central South University, China</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Sui-xin Liu, Cardiac Rehabilitation Center, Department of
Rehabilitation, Xiangya Hospital, Central South University: Xiang-Ya Road 87, 41008,
Changsha, Hunan, China. (E-mail: <email xlink:href="heartsuixin@126.com">heartsuixin@126.com</email>)</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>7</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2015</year></pub-date><volume>27</volume><issue>7</issue><fpage>2365</fpage><lpage>2371</lpage><history><date date-type="received"><day>06</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>18</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>2015&#x000a9;by the Society of Physical Therapy Science. Published by IPEC
Inc.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>[Purpose] To investigate the effects of combined aerobic and resistance training on
glycolipid metabolism and inflammation levels in type 2 diabetes mellitus patients.
[Subjects and Methods] Forty-two diabetes patients were randomized to the conventional
therapy group (<italic>n</italic> = 20) or intensive therapy group (<italic>n</italic> =
22). The control group contained 20 healthy people. The conventional therapy group
received routine drug therapy and diet control, while the intensive therapy group
additionally underwent combined aerobic and resistance training for 12 weeks. The oral
glucose tolerance test and cardiopulmonary exercise testing were performed. Toll-like
receptor 4 and NF-&#x003ba;Bp65 protein and mRNA expressions were determined by qPCR and western
blotting. ELISA was used to determine the expression levels of interleukin-18,
interleukin-33, pentraxin-related protein 3, and human cartilage glycoprotein 39.
[Results] After exercise training, the intensive therapy group had significantly lower
postprandial blood glucose, postprandial insulin, and glycated hemoglobin level and
insulin resistance index than the conventional therapy group. The intensive therapy group
had significantly lower toll-like receptor 4 and NF-&#x003ba;Bp65 protein and mRNA expressions,
and serum interleukin-18 levels but significantly higher serum interleukin-33 levels.
[Conclusion] Combined aerobic and resistance training can improve glycolipid metabolism
and reduce low-grade inflammation in patients with diabetes mellitus patients.</p></abstract><kwd-group><title>Key words</title><kwd>Type 2 diabetes mellitus</kwd><kwd>Exercise therapy</kwd><kwd>In&#x0fb02;ammation</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Late-stage diabetes is always associated with multiple chronic complications that lead to
extremely high rates of mortality and disability. Therefore, understanding the pathogenic
mechanism of diabetes mellitus is essential. Diabetes mellitus is usually associated with
hereditary and environmental factors. The disease has recently been regarded as a chronic
low-grade inflammatory disease whose onset is characterized with persistent low-grade
inflammation<xref rid="r1" ref-type="bibr">1</xref><sup>)</sup>. The latest studies
confirm the significant elevation of tumor necrosis factor-alpha (TNF-&#x003b1;), interleukin
(IL)-6, C-reactive protein (CRP), etc. in diabetes<xref rid="r2" ref-type="bibr">2</xref>,
<xref rid="r3" ref-type="bibr">3</xref><sup>)</sup>. In addition, diabetes patients
exhibit abnormal expression of adipokines such as leptin, resistin, and adiponectin,
indicating chronic low-grade inflammation<xref rid="r3" ref-type="bibr">3</xref><sup>)</sup>. Furthermore, inflammatory factors involved in the genesis of insulin
resistance (IR) also contribute to the pathogenesis and progression of diabetes. Those
findings strongly indicate a close association between low-grade inflammations and type 2
diabetes mellitus (T2DM).</p><p>Exercise therapy is recommended for the treatment of diabetes. Regular exercise improves
glycolipid metabolism and IR, thereby reducing diabetes-associated complications.
Furthermore, exercise improves chronic inflammation<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>. Exercise can reduce systemic low-grade inflammation and thus
effectively improve chronic inflammatory diseases such as obesity, metabolic syndrome,
diabetes mellitus, ageing, etc.<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r6" ref-type="bibr">6</xref><sup>)</sup>. It can decrease the levels of inflammatory
factors such as TNF-&#x003b1;, IL-6, CRP<xref rid="r7" ref-type="bibr">7</xref>, <xref rid="r8" ref-type="bibr">8</xref><sup>)</sup>, and leptin<xref rid="r9" ref-type="bibr">9</xref><sup>)</sup> while increasing the levels of anti-inflammatory factors such as
IL-4, IL-10, and adiponectin in diabetes patients<xref rid="r10" ref-type="bibr">10</xref>,
<xref rid="r11" ref-type="bibr">11</xref><sup>)</sup>. Exercise also reduces the
inflammation level and improves IR by enhancing anti-stress and anti-oxidative effects.
Nevertheless, the anti-inflammatory mechanism induced by exercise is complex and
incompletely understood.</p><p>Toll-like receptor 4 (TLR4) is a major member of TLR family, which acts as a core mediator
of innate immunity. TLR4 is an important receptor for the chronic inflammatory response
because it is closely related to the inflammatory response. It substantially increases the
expressions of inflammatory factors such as TNF-&#x003b1;, IL-6, and IL-1 by regulating the
activities of transcription factors such as NF-&#x003ba;B<xref rid="r12" ref-type="bibr">12</xref><sup>)</sup>; this creates a persistent low-level chronic inflammatory response
and IR <italic>in vivo</italic>. Under oxidative stress, NF-&#x003ba;B also activates its inhibitor
and increases the serine phosphorylation of insulin receptors and insulin receptor
substrate, leading to IR<xref rid="r13" ref-type="bibr">13</xref><sup>)</sup>. Thus, TLR4
and NF-&#x003ba;B play pivotal roles in generating an inflammatory response <italic>in
vivo.</italic> Therefore, they might play critical roles in the pathogenesis and
progression of diabetes. Accordingly, the present study investigated the long-term effects
of a combination of aerobic and resistance exercises for 12 weeks on TLR4, NF-&#x003ba;B, and
inflammatory factors in diabetes patients. Thus, we aimed to provide a theoretical basis to
encourage exercise therapy for patients with diabetes.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>From March 2012 to March 2014, 42 patients with non-insulin-dependent T2DM were selected
from among the outpatients visiting the Department of Cardiovascular Rehabilitation, Xiangya
Hospital, Central South University, Changsha, China. The patients were randomized to the
conventional therapy group (CT group, <italic>n</italic> = 20) or the intensive therapy
group (IT group, <italic>n</italic> = 22). The CT group received regular drug treatment and
diet guidance, while the IT group additionally performed aerobic and resistance exercises
for 12 weeks. Furthermore, 20 healthy people were included as a control group. The inclusion
criteria were as follows: (1) meeting the diagnostic criteria proposed by the World Health
Organization in 1999, patients who presented diabetes symptoms, serum glucose level &#x02265;
11.1&#x02005;mmol/L when detected randomly, fasting blood glucose &#x02265; 7.0&#x02005;mmol/L, and oral glucose
tolerance test (OGTT) showing a 2-hour postprandial blood glucose (PBG) &#x02265; 11.1&#x02005;mmol/L; (2)
no severe complications such as acute infectious diseases, numbness of limbs, decreased
visual acuity, and diabetic nephropathy, retinopathy, or foot; (3) no severe cardiovascular
or cerebrovascular diseases such as severe arrhythmia, or acute myocardial infarction or
stroke, or severe joint disease leading to poor exercise tolerance; and (4) no frequent
exercise (exercise frequency less than twice per week for less than 15 minutes). We obtained
patients&#x02019; written informed consent to participant in this study. The study procedures were
approved by the Institutional Review Board of Central South University, Changsha, China. All
procedures conformed to the standards set by the Declaration of Helsinki.</p><p>Cardiopulmonary Exercise Testing (CPET) was performed on all participants before the
intervention in a laboratory with 50&#x02013;55% humidity and at a temperature of 24&#x02013;25&#x000b0;C. The
maximum oxygen consumption (VO<sub>2max</sub>) was defined as the highest value of oxygen
consumption measured during the exercise period. Using an incremental and symptom-limited
protocol, participants made their efforts to their maximal capacity on a cycle ergometer
(SCHILLER CS-200, Switzerland). During the exercise, the cadence was held at a constant
speed of 60 rep/min. The initial workload was 10&#x02013;20 W, and then increased by 10&#x02013;20 W/min.
Finally, the test was terminated when any of the following symptoms occured, such as
fatigue, dyspnea, angina, adverse changes in blood pressure, musculoskeletal complaint, and
electrocardiographic evidence of ischemia or arrhythmia. Blood pressure and ECG were
monitored throughout the whole testing. The test usually lasted 6&#x02013;12 minutes. Participants
were also asked to self report the intensity of exercise by the Borg scale of rate of
perceived exertion (RPE)<xref rid="r14" ref-type="bibr">14</xref><sup>)</sup>.</p><p>All the subjects in the IT group received a combined home-based exercise program and
supervised exercise training at the Department of Cardiovascular Rehabilitation, Xiangya
Hospital, Central South University. These subjects took part in at least 3&#x02013;10 supervised
training sessions at hospital at the beginning of the program. Each subject received
in-person instructions on how to exercise at a moderate-intensity level, how to monitor
heart rate, how to use the resistant band, and how to acquire an individualized home-based
exercise program. The intervention was gradually shifted to home-based exercise for the rest
time of total 12 weeks, as the subjects were familiar with the whole exercise procedure. The
exercise program mainly consisted of the aerobic exercise and the resistance training.
Aerobic exercise was conducted for a total of 40&#x02013;60 minutes per session, 3 sessions per
week. The exercise intensity for each patient set at 40&#x02013;60% of his/her VO<sub>2 max</sub>.
The exercise was started at a low intensity of 40%VO<sub>2max</sub> for 10 minutes. As the
weeks progressed, the exercise intensity was increased to 60%VO<sub>2max</sub>, while the
duration was increased to 30 minutes over the period of 1 month. The aerobic exercise
session generally consisted of a 10-minute warm-up period and a 15-minute cool-down period.
Pulse palpation method was performed to monitor heart rate<xref rid="r15" ref-type="bibr">15</xref><sup>)</sup>. RPE (12&#x02013;13 on the Borg scale) was also used to assist in
estimating the moderate exercsie intensity<xref rid="r16" ref-type="bibr">16</xref><sup>)</sup>. The patients also performed a moderate-intensity (i.e., 50&#x02013;60% of
the one repetition maximum, 1RM) resistance training program 2&#x02013;3 times per week. 1RM was
roughly estimated by several Load-Repetition tests<xref rid="r17" ref-type="bibr">17</xref><sup>)</sup>. The subjects performed all resistance exercises with 8&#x02013;10
repetitions in two sets by using an elastic band (Thera-band; Hygenic Corporation, Akron,
OH, USA). Resistance training intensity commenced at 50% of 1RM and increased to 60% in the
fourth week of the program. In addition, the RPE (11&#x02013;14 on the Borg scale) was also used to
monitor the training intensity. The patients were instructed to avoid the Valsalva maneuver
during the resistance training program. Weight and blood pressure were checked regularly
during the exercise training. In addition to the training, routine diet guidance and
psychological counseling were provided. All the subjects had to visit the hospital to make
sure the right home-based exercise program every month. Furthermore, the telephone
consultation was applied to enhance the compliance of these subjects and check out the
individual feedback during the exercise procedure. The telephone consultation lasted for
5&#x02013;10 minutes and was offered once a week for 3 months<xref rid="r18" ref-type="bibr">18</xref><sup>)</sup>.</p><p>The OGTT was performed before and after the intervention, and the results were recorded in
detail. All blood samples were drawn from an antecubital vein. Plasma glucose concentrations
were analyzed by glucose oxidase method, and insulin levels were measured using RIA kit
(Beijing North Institute, Beijing, China). Serum glycosylated hemoglobin (HbAlc) was
measured by affinity chromatography. Serum total cholesterol (TC), low-density lipoprotein
(LDL), high density lipoprotein (HDL), and triglyceride (TG) concentrations were determined
by using a Cobas Fara robot (Roche, Switzerland). Insulin resistance index (IRI) was
calculated using the method of homeostatic model assessment (HOMA)<xref rid="r19" ref-type="bibr">19</xref><sup>)</sup>. The specific formula was:
IRI=[FBG(mmol/L)&#x000d7;FIN(&#x000b5;IU/mL)]/22.5. Venous blood (15&#x02005;mL) was drawn from each participant and
subjected to Ficoll-Hypaque density gradient centrifugation in order to separate mononuclear
cells; 5&#x02005;mL venous blood was used for quantitative polymerase chain reaction (qPCR) to
detect the expression levels of TLR4 and NF-&#x003ba;B mRNA, while the remaining 10&#x02005;mL was used to
detect the expression levels of TLR4 and NF-&#x003ba;B proteins. Sera were analyzed by ELISA to
determine the expression levels of IL-18, IL-33, PTX3, and YKL40.</p><p>The mononuclear cells were treated with lysis buffer, and 30&#x02005;&#x000b5;g total protein was loaded
and separated on a 10% SDS-PAGE gel before transfer to a nitrocellulose membrane.
Immunoblots were incubated with primary antibodies as per the indicated dilution. &#x003b2;-actin
was used as a loading control. After incubating with the recommended horseradish peroxidase
secondary antibodies, signals were detected using enhanced chemiluminescence.
Chemiluminescence fluorescence image analysis system was used to scan fluorescence images
and various optical density value (OD value) was calculated by Bandscan image analysis
software. The relative expression of target genes was determined by the the ratio of OD
value of the target genes to that of internal reference gene.</p><p>Total RNA was extracted from the mononuclear cells using TRIzol reagent (Invitrogen,
Waltham, MA, USA) according to the manufacturer&#x02019;s instructions. The expressions of TLR4 and
NF-&#x003ba;Bp65 mRNA were detected by SYBR green qPCR assay (Bio-Rad, Hercules, CA, USA). The
speci&#x0fb01;c primers were as follows: TLR4 forward: 5&#x02032;- TGGGTAAGGAATGAGCTAGTAAA -3&#x02032;, reverse:5&#x02032;-
GCTGGGACACCACAACAA -3&#x02032;; &#x003b2;-actin forward: 5&#x02032;- CATCCTGCGTCTGGACCTGG-3&#x02032;, reverse:
5&#x02032;-TAATGTCACGCACGATTTCC-3&#x02032;; NF-&#x003ba;Bp65 forward:5&#x02032;- -CCCATCGGGTTCCCATAAAG-3&#x02032;, reverse:
5&#x02032;-GCCTGAAGCAAATGTTGGCGTA-3&#x02032;. All reactions were performed in triplicate. &#x003b2;-actin was used
as an endogenous control for TLR4 and NF-&#x003ba;Bp65. The 2&#x02212;&#x00394;&#x00394;CT method was used to process the
data.</p><p>The biochemical analyses of serum IL-18, IL-33, PTX3, and YKL40 were performed by ELISA
(Abcam, MA, USA); human IL-18, IL-33, PTX3, and YKL40 were detected quantitatively. All
factors were quantified using polyclonal antibodies that recognized native human IL-18,
IL-33, PTX3, or YKL40 and a series of plates containing wells coated with predetermined
amounts of recombinant human IL-18, IL-33, PTX3, or YKL40.</p><p>All statistical analyses were performed using SPSS version 19.0. Continuous variables are
expressed as mean &#x000b1; standard deviation and were compared using the Student-Newman-Keuls
test. The insulin resistance index (IRI) showed a skewed distribution and a natural
logarithmic transformation was performed befor statistical analysis. The level of
significance was set at p &#x0003c; 0.05.</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p>The diabetes groups did not differ significantly from the normal control group with respect
to age (52.59 &#x000b1; 11.43 vs. 51.20 &#x000b1; 11.34&#x02005;years) or gender (F30/M12 vs. F13/M7). Compared to
the CT group, Fasting Blood Glucose (FBG), Postprandial Blood Glucose (PBG), Fasting Plasma
Insulin (FIN), Postprandial Plasma Insulin (PIN), HbA1c, ln HOMA-IR, TG, TC, HDL, and LDL
levels were not significantly different between the CT and IT groups (all p &#x0003e; 0.05, <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Changes of serum glucose, insulin, HOMA-IR, and blood lipids</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" valign="middle" align="center" colspan="1">Variables</th><th colspan="2" valign="middle" align="center" rowspan="1">CT group (n = 20) </th><th colspan="2" valign="middle" align="center" rowspan="1">IT group (n = 22) </th><th rowspan="3" valign="middle" align="center" colspan="1">Control group (n = 20)</th></tr><tr><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Pre-treatment</th><th valign="top" align="center" rowspan="1" colspan="1">Post-treatment</th><th valign="top" align="center" rowspan="1" colspan="1">Pre-treatment</th><th valign="top" align="center" rowspan="1" colspan="1">Post-treatment</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">FBG (mmol/L)</td><td align="center" rowspan="1" colspan="1">7.14 &#x000b1; 1.97</td><td align="center" rowspan="1" colspan="1">6.37 &#x000b1; 1.40**</td><td align="center" rowspan="1" colspan="1">6.84 &#x000b1; 1.42</td><td align="center" rowspan="1" colspan="1">5.78 &#x000b1; 0.48**</td><td align="center" rowspan="1" colspan="1">5.65 &#x000b1; 0.41</td></tr><tr><td align="left" rowspan="1" colspan="1">PBG (mmol/L)</td><td align="center" rowspan="1" colspan="1">11.08 &#x000b1; 2.63</td><td align="center" rowspan="1" colspan="1">9.00 &#x000b1; 1.91**</td><td align="center" rowspan="1" colspan="1">11.30 &#x000b1; 2.17</td><td align="center" rowspan="1" colspan="1">7.30 &#x000b1; 0.98<sup>** &#x00394;&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">6.26 &#x000b1; 1.04</td></tr><tr><td align="left" rowspan="1" colspan="1">FIN (&#x003bc;U/mL)</td><td align="center" rowspan="1" colspan="1">12.81 &#x000b1; 6.16</td><td align="center" rowspan="1" colspan="1">11.65 &#x000b1; 5.26</td><td align="center" rowspan="1" colspan="1">13.40 &#x000b1; 5.11</td><td align="center" rowspan="1" colspan="1">9.04 &#x000b1; 3.19**</td><td align="center" rowspan="1" colspan="1">9.19 &#x000b1; 3.73</td></tr><tr><td align="left" rowspan="1" colspan="1">PIN (&#x003bc;U/mL)</td><td align="center" rowspan="1" colspan="1">94.54 &#x000b1; 46.05</td><td align="center" rowspan="1" colspan="1">69.67 &#x000b1; 31.30**</td><td align="center" rowspan="1" colspan="1">83.66 &#x000b1; 30.75</td><td align="center" rowspan="1" colspan="1">36.16 &#x000b1; 18.26<sup>**&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">34.50 &#x000b1; 11.74</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HbA1c (%)</td><td align="center" rowspan="1" colspan="1">6.88 &#x000b1; 0.76</td><td align="center" rowspan="1" colspan="1">6.44 &#x000b1; 0.65**</td><td align="center" rowspan="1" colspan="1">6.85 &#x000b1; 1.14</td><td align="center" rowspan="1" colspan="1">5.89 &#x000b1; 0.61<sup>** &#x00394;&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">5.73 &#x000b1; 0.31</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA-IR</td><td align="center" rowspan="1" colspan="1">4.23 &#x000b1; 2.99</td><td align="center" rowspan="1" colspan="1">3.32 &#x000b1; 1.73</td><td align="center" rowspan="1" colspan="1">4.11 &#x000b1; 1.98</td><td align="center" rowspan="1" colspan="1">2.33 &#x000b1; 0.92</td><td align="center" rowspan="1" colspan="1">2.30 &#x000b1; 0.94</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ln HOMA-IR</td><td align="center" rowspan="1" colspan="1">1.26 &#x000b1; 0.60</td><td align="center" rowspan="1" colspan="1">1.08 &#x000b1; 0.50</td><td align="center" rowspan="1" colspan="1">1.33 &#x000b1; 0.40</td><td align="center" rowspan="1" colspan="1">0.77 &#x000b1; 0.40<sup>**&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">0.74 &#x000b1; 0.43</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TG (mmol/L)</td><td align="center" valign="top" rowspan="1" colspan="1">1.99 &#x000b1; 1.07</td><td align="center" valign="top" rowspan="1" colspan="1">1.75 &#x000b1; 0.76</td><td align="center" valign="top" rowspan="1" colspan="1">2.20 &#x000b1; 1.27</td><td align="center" valign="top" rowspan="1" colspan="1">1.17 &#x000b1; 0.35** <sup>&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">1.13 &#x000b1; 0.31</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TC (mmol/L)</td><td align="center" valign="top" rowspan="1" colspan="1">4.62 &#x000b1; 1.31</td><td align="center" valign="top" rowspan="1" colspan="1">4.45 &#x000b1; 1.12</td><td align="center" valign="top" rowspan="1" colspan="1">5.53 &#x000b1; 1.65</td><td align="center" valign="top" rowspan="1" colspan="1">4.77 &#x000b1; 1.03*</td><td align="center" rowspan="1" colspan="1">3.91 &#x000b1; 0.56</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HDL (mmol/L)</td><td align="center" valign="top" rowspan="1" colspan="1">1.27 &#x000b1; 0.31</td><td align="center" valign="top" rowspan="1" colspan="1">1.31 &#x000b1; 0.30</td><td align="center" valign="top" rowspan="1" colspan="1">1.38 &#x000b1; 0.29</td><td align="center" valign="top" rowspan="1" colspan="1">1.43 &#x000b1; 0.26</td><td align="center" rowspan="1" colspan="1">1.38 &#x000b1; 0.19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDL (mmol/L)</td><td align="center" valign="top" rowspan="1" colspan="1">2.58 &#x000b1; 1.00</td><td align="center" valign="top" rowspan="1" colspan="1">2.46 &#x000b1; 1.02</td><td align="center" valign="top" rowspan="1" colspan="1">3.22 &#x000b1; 1.47</td><td align="center" valign="top" rowspan="1" colspan="1">2.54 &#x000b1; 1.22*</td><td align="center" rowspan="1" colspan="1">2.08 &#x000b1; 0.38</td></tr></tbody></table><table-wrap-foot><p>Data are mean &#x000b1; SD. *p <italic>&#x0003c;</italic> 0.05, **p <italic>&#x0003c;</italic> 0.01 vs.
pre-treatment; <sup>&#x00394;</sup>p <italic>&#x0003c;</italic> 0.05, <sup>&#x00394;&#x00394;</sup>p
<italic>&#x0003c;</italic> 0.01 vs. conventional therapy group. FBG: fasting blood
glucose; FIN: fasting insulin; HbA1c: glycated hemoglobin; HOMA-IR: the index for
homeostasis model assessment of insulin resistance; LDL: low-density lipoprotein; PBG:
postprandial blood glucose (2-h); PIN: postprandial insulin (2-h); TC: total
cholesterol; TG: triglycerides</p></table-wrap-foot></table-wrap>).</p><p>In the CT group, FBG, PBG, PIN, and HbA1c decreased significantly after treatment
(p<italic> &#x0003c;</italic>0.05, &#x0003c;0.01). Meanwhile, FBG, PBG, FIN, PIN, HbA1c, and ln
HOMA-IR decreased significantly in the IT group, (all p<italic> &#x0003c;</italic> 0.01). PBG,
PIN, HbA1c, and ln HOMA-IR were significantly lower in the IT group than the CT group
(p<italic> &#x0003c;</italic>0.01, <italic>&#x0003c;</italic>0.05, <xref rid="tbl_001" ref-type="table">Table 1</xref>).</p><p>Before treatment, the mRNA and protein expression levels of TLR4 and NF-&#x003ba;Bp65, and serum
IL-18 level were significantly higher in the CT and IT groups than the control group, while
IL-33 level were significantly lower in the CT and IT groups (p<italic> &#x0003c;</italic>0.05,
<italic>&#x0003c;</italic>0.01). After the exercise intervention, the mRNA and protein
expressions of TLR4 and NF-&#x003ba;Bp65 were significantly lower in the IT group than the CT group
(p<italic> &#x0003c;</italic>0.05, <italic>&#x0003c;</italic>0.01). The melting and amplification
curves of TLR4 and NF-&#x003ba;B mRNA detected by qPCR are shown in <xref ref-type="fig" rid="fig_001">Fig. 1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig.1.</label><caption><p>Melting and amplification curves of TLR4 mRNA and NF-&#x003ba;B mRNA detected by qPCR. NF-&#x003ba;B:
Nuclear factor-&#x003ba;B; TLR4: Toll-like receptor 4</p></caption><graphic xlink:href="jpts-27-2365-g001"/></fig>. Serum IL-18 level was significantly lower in the IT group than the CT group
(p<italic> &#x0003c;</italic> 0.05). Meanwhile, the serum IL-33 level was significantly higher
in the IT group than the CT group but lower than that in the control group (p<italic>
&#x0003c;</italic> 0.05). There was no significant difference in the expression levels of PTX3
or YKL40 among the three groups (<xref rid="tbl_002" ref-type="table">Table
2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Effects of exercise intervention on the inflammatory factors in diabetes
patients</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" valign="middle" align="center" colspan="1">Items</th><th colspan="2" valign="middle" align="center" rowspan="1">CT group (n = 20)</th><th colspan="2" valign="middle" align="center" rowspan="1">IT group (n = 22)</th><th rowspan="3" valign="middle" align="center" colspan="1">Control group (n = 20)</th></tr><tr><th colspan="2" rowspan="1"><hr/></th><th colspan="2" rowspan="1"><hr/></th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Pre-treatment</th><th valign="top" align="center" rowspan="1" colspan="1">Post-treatment</th><th valign="top" align="center" rowspan="1" colspan="1">Pre-treatment</th><th valign="top" align="center" rowspan="1" colspan="1">Post-treatment</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">TLR4 mRNA</td><td align="center" rowspan="1" colspan="1">1.68 &#x000b1; 0.29**</td><td align="center" rowspan="1" colspan="1">0.77 &#x000b1; 0.18</td><td align="center" rowspan="1" colspan="1">1.85 &#x000b1; 0.31**</td><td align="center" rowspan="1" colspan="1">0.54 &#x000b1; 0.63**<sup>&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">1.05 &#x000b1; 0.18</td></tr><tr><td align="left" rowspan="1" colspan="1">NF-&#x003ba;Bp65mRNA</td><td align="center" rowspan="1" colspan="1">1.28 &#x000b1; 0.26**</td><td align="center" rowspan="1" colspan="1">1.01 &#x000b1; 0.11</td><td align="center" rowspan="1" colspan="1">1.41 &#x000b1; 1.77**</td><td align="center" rowspan="1" colspan="1">0.86 &#x000b1; 0.66<sup>&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">0.86 &#x000b1; 0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">TLR4 protein</td><td align="center" rowspan="1" colspan="1">0.95 &#x000b1; 0.34**</td><td align="center" rowspan="1" colspan="1">0.67 &#x000b1; 0.33*</td><td align="center" rowspan="1" colspan="1">0.86 &#x000b1; 0.25**</td><td align="center" rowspan="1" colspan="1">0.41 &#x000b1; 0.16<sup>&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">0. 45 &#x000b1; 0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">NF-&#x003ba;Bp65 protein</td><td align="center" rowspan="1" colspan="1">0.88 &#x000b1; 0.36**</td><td align="center" rowspan="1" colspan="1">0.64 &#x000b1; 0.25*</td><td align="center" rowspan="1" colspan="1">0.85 &#x000b1; 0.24**</td><td align="center" rowspan="1" colspan="1">0.49 &#x000b1; 0.21<sup>&#x00394;&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">0.45 &#x000b1; 0.21</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">YKL40</td><td align="center" rowspan="1" colspan="1">0.41 &#x000b1; 0.11</td><td align="center" rowspan="1" colspan="1">0.34 &#x000b1; 0.21</td><td align="center" rowspan="1" colspan="1">0.31 &#x000b1; 0.14</td><td align="center" rowspan="1" colspan="1">0. 28 &#x000b1; 0.09</td><td align="center" rowspan="1" colspan="1">0.27 &#x000b1; 0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-18</td><td align="center" valign="top" rowspan="1" colspan="1">0.80 &#x000b1; 0.12**</td><td align="center" valign="top" rowspan="1" colspan="1">0.72 &#x000b1; 0.12*</td><td align="center" valign="top" rowspan="1" colspan="1">0.81 &#x000b1; 0.09**</td><td align="center" valign="top" rowspan="1" colspan="1">0.51 &#x000b1; 0.10<sup>&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">0.59 &#x000b1; 0.31</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PTX3</td><td align="center" valign="top" rowspan="1" colspan="1">0.63 &#x000b1; 0.13</td><td align="center" valign="top" rowspan="1" colspan="1">0.63 &#x000b1; 0.14</td><td align="center" valign="top" rowspan="1" colspan="1">0.64 &#x000b1; 0.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.58 &#x000b1; 0.08</td><td align="center" rowspan="1" colspan="1">0.54 &#x000b1; 0.78</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IL-33</td><td align="center" valign="top" rowspan="1" colspan="1">0.40 &#x000b1; 0.09**</td><td align="center" valign="top" rowspan="1" colspan="1">0.65 &#x000b1; 0.12*</td><td align="center" valign="top" rowspan="1" colspan="1">0.42 &#x000b1; 0.14**</td><td align="center" valign="top" rowspan="1" colspan="1">0.85 &#x000b1; 0.14*<sup>&#x00394;&#x00394;</sup></td><td align="center" rowspan="1" colspan="1">1.38 &#x000b1; 0.19</td></tr></tbody></table><table-wrap-foot><p>Data are mean &#x000b1; SD, *p <italic>&#x0003c;</italic> 0.05, **p <italic>&#x0003c;</italic> 0.01 vs.
control group; <sup>&#x00394;</sup>p <italic>&#x0003c;</italic> 0.05, <sup>&#x00394;&#x00394;</sup>p
<italic>&#x0003c;</italic> 0.01 vs. conventional therapy group. CT group: the
conventional therapy group; IT group: the intensive therapy group; IL-18:
interleukin-18; IL-33: interleukin-33; NF-&#x003ba;Bp65: Nuclear factor-&#x003ba;Bp65; PTX3:
pentraxin-related protein 3; TLR4: Toll-like receptor 4; YKL40: human cartilage
glycoprotein 39</p></table-wrap-foot></table-wrap> and <xref ref-type="fig" rid="fig_002">Fig. 2</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>Changes in the protein expressions of TLR4 and NF-&#x003ba;Bp65 before and after the
intervention. A: control group; B: conventional therapy group before intervention; C:
conventional therapy group after intervention; D: intensive-therapy group before
intervention; E: intensive therapy group after intervention. NF-&#x003ba;Bp65: Nuclear
factor-&#x003ba;Bp65; LR4: Toll-like receptor 4</p></caption><graphic xlink:href="jpts-27-2365-g002"/></fig>).</p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>Exercise therapy is an effective method for treating diabetes mellitus. Many studies show
aerobic exercise including home-based exercise decreases blood glucose, lipid, and HbA1c
levels as well as improves insulin sensitivity, hypercoagulability state, quality of life,
and physical condition in T2DM patients<xref rid="r20" ref-type="bibr">20</xref>,<xref rid="r21" ref-type="bibr">21</xref>,<xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref><sup>)</sup>. In the present study, T2DM patients
performed a combination of aerobic exercises and resistance training for 12 weeks. The
results show significant improvements in the fasting and postprandial blood glucose, HbA1c,
TG, TC, LDL cholesterol, and IR in the intensive-therapy group after 12 weeks of therapy
compared to conventional therapy. Balducci et al.<xref rid="r26" ref-type="bibr">26</xref><sup>)</sup> report that compared to conventional therapies, a 1&#x02005;year exercise
intervention significantly reduced the blood glucose, TG, TC, and LDL cholesterol levels of
patients with T2DM while significantly increasing HDL cholesterol level. Tokmakidis et
al.<xref rid="r27" ref-type="bibr">27</xref><sup>)</sup> report that a 4-month exercise
intervention significantly reduced the fasting and (2-hour) postprandial blood glucose,
insulin, and HbA1c levels of diabetes patients. Thus, the present results are concordant
with those of Balducci et al. and Tokmakidis et al. Among diabetes patients, regular
exercise has a better blood glucose-controlling effect, because it improves insulin
sensitivity. Moreover, regular exercise enhances blood pressure and blood lipid control,
thus reducing the risks of large vascular and microvascular complications.</p><p>Despite the attention of many researchers for a long time, the underlying pathogenic
mechanism of diabetes mellitus remains unclear. The latest studies indicate a close
association between the pathogenesis of diabetes mellitus and a chronic low-grade
inflammatory response. In the present study, the mRNA and protein expression levels of TLR4
and NF-&#x003ba;B in mononuclear cells as well as serum levels of the inflammatory factor IL-18 were
higher in T2DM patients than healthy controls. However, the expression level of the
protective cytokine IL-33 was lower in T2DM patients than control group. Meanwhile, the
serum inflammatory factors PTX3 and YKL40 did not differ significantly between T2DM patients
and controls. These results indicate TLR4, NF-&#x003ba;B, IL-18, and IL-33 may play important roles
in the pathogenesis of diabetes mellitus. Previous studies report that patients with
diabetes mellitus have higher TLR4 mRNA and protein expression in mononuclear cells and that
these changes are closely associated with blood glucose and HbA1c levels<xref rid="r28" ref-type="bibr">28</xref><sup>)</sup>. Another study reports the same findings
in patients with metabolic syndrome<xref rid="r29" ref-type="bibr">29</xref><sup>)</sup>.
TLR4 activates several cell signaling pathways, particularly the TLR4/NF-&#x003ba;B pathway. NF-&#x003ba;B
subsequently activates a series of inflammatory factors including TNF-&#x003b1;, IL-1, IL-6, and
IL-8 and induces the expressions of several adherence factors and chemokines by mononuclear
macrophages and endothelial cells<xref rid="r30" ref-type="bibr">30</xref><sup>)</sup>. This
cascade ultimately results in IR and secretary dysfunction of insulin in the body. IL-18 is
mainly secreted by mononuclear macrophages and may be important for generating an
inflammatory response<xref rid="r31" ref-type="bibr">31</xref><sup>)</sup>. Some studies
report diabetes patients have elevated plasma IL-18 expression, which is closely associated
with fasting blood glucose and HbA1c levels<xref rid="r32" ref-type="bibr">32</xref><sup>)</sup>. In addition, elevated IL-18 expression is reported to be an
independent risk factor for the development of diabetes mellitus<xref rid="r33" ref-type="bibr">33</xref><sup>)</sup>. IL-33, a member of the IL-1 cytokine family, is released
after cell damage or as a negative regulator of NF-&#x003ba;B gene transcription; it not only
enhances cytokine production by T helper cells, but also reduces the activities of natural
killer cells and the generation of oxidation products; therefore, it is recognized as a
protective factor against IR, diabetes mellitus, and obesity. Elevated IL-33 expression
improves fasting blood glucose and glucose tolerance<xref rid="r34" ref-type="bibr">34</xref>, <xref rid="r35" ref-type="bibr">35</xref><sup>)</sup>. On the contrary, the
removal of IL-33 may increase the cytotoxicity of natural killer cells and trigger
inflammatory factors such as TNF-&#x003b1;, possibly resulting in IR<xref rid="r36" ref-type="bibr">36</xref><sup>)</sup>. These studies are consistent with the results of the present
study. Although some studies show PTX3 and YKL40 are associated with the onset and
progression of diabetes<xref rid="r37" ref-type="bibr">37</xref>, <xref rid="r38" ref-type="bibr">38</xref><sup>)</sup>, we found no significant increases of their expression
levels. This discrepancy is probably due to the variation in the duration and type of
disease of our patients. The present results indicate diabetes patients exhibit increased
expressions of some inflammatory factors and decreased expressions of protective cytokines,
indicating a close relationship between diabetes mellitus and a chronic low-grade
inflammatory response.</p><p>Long-term regular exercise can reduce chronic low-level inflammation in humans, and an
exercise-containing lifestyle may also delay the genesis and development of T2DM<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r39" ref-type="bibr">39</xref><sup>)</sup>.
There was research also demontrated that the home-based exercise improved the metabolic
asset and reduced the systemic inflammation of sedentary people<xref rid="r40" ref-type="bibr">40</xref><sup>)</sup>. Another study proved that home-based exercise could
improve clinical features and systemic inflammation of patients with chronic obstructive
pulmonary disease<xref rid="r41" ref-type="bibr">41</xref><sup>)</sup>. In the present
study, the intensive intervention program for diabetes patients included a 12-week
moderate-intensity workout program consisting of aerobic exercise and resistance training
(i.e., the IT group). After exercise training, the IT group had significantly lower TLR4 and
NF-&#x003ba;B mRNA and protein expressions as well as serum IL-18 levels than the CT group.
Meanwhile, the serum level of IL-33 (a protective cytokine) was significantly higher in the
IT group than the CT group but lower than that in the control group. Exercise can
significantly reduce TLR4 expression on the surface of mononuclear cells in non-diabetes
patients<xref rid="r42" ref-type="bibr">42</xref>, <xref rid="r43" ref-type="bibr">43</xref><sup>)</sup>. Lambert et al. also report a similar reduction in elderly obese
patients following long-term exercise therapy<xref rid="r44" ref-type="bibr">44</xref><sup>)</sup>. Other studies also demonstrate that exercise reduces IL-18 levels
in elderly people and patients with metabolic syndrome<xref rid="r45" ref-type="bibr">45</xref>, <xref rid="r46" ref-type="bibr">46</xref><sup>)</sup>. Furthermore, regular
exercise increases the expressions of heat shock proteins and IL-33 by vascular endothelial
cells. These findings are concordant with the results of the present study. The present
study suggests the anti-inflammatory mechanism of long-term medium-intensity exercise may be
associated with decreased mRNA and protein expressions of TLR4 and NF-&#x003ba;B, and the
inflammatory factor IL-18 as well as elevated levels of the anti-inflammatory factor IL-33,
all of which improve IR and the outcome of diabetes.</p><p>This study has some limitations that should be mentioned. As the sample size was relatively
small, our results may be affected by some biases. Moreover, the mechanism by which exercise
intervention alters the gene expressions of inflammatory factors remains unclear. Therefore,
further animal and cellular experiments must be conducted to clarify the underlying
mechanism of exercise intervention.</p><p>In conclusion, the present study demonstrates the existence of low-grade chronic
inflammation in diabetes patients and that long-term medium-intensity exercise can not only
decrease the mRNA and protein expressions of TLR4 and NF-&#x003ba;B, but can also reduce the level
of the inflammatory factor IL-18 and increase the level of the anti-inflammatory factor
IL-33. Thus, long-term moderate-intensity exercise can resolve inflammatory response,
improve IR, and achieve better blood glucose control in T2DM patients. Hence, exercise
intervention can minimize the incidence of T2DM-associated complications. Therefore,
exercise therapy should be widely recommended to patients with T2DM.</p></sec></body><back><ack><p>The authors acknowledge the contributions of all the clinical staff members of the Cardiac
Rehabilitation Center of Xiangya Hospital. We also thank the Lihua Jiang, Lihue Deng, Cui
Li, Fan Zheng, and Zhuo Chen, who helped with data collection.</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Duncan</surname><given-names>BB</given-names></name><name><surname>Schmidt</surname><given-names>MI</given-names></name></person-group>: <article-title>The epidemiology of low-grade chronic systemic
inflammation and type 2 diabetes</article-title>. <source>Diabetes Technol
Ther</source>, <year>2006</year>, <volume>8</volume>: <fpage>7</fpage>&#x02013;<lpage>17</lpage>.
<pub-id pub-id-type="pmid">16472046</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Pradhan</surname><given-names>AD</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><etal>et al.</etal></person-group>: <article-title>C-reactive protein, interleukin 6, and risk of developing
type 2 diabetes mellitus</article-title>. <source>JAMA</source>, <year>2001</year>,
<volume>286</volume>: <fpage>327</fpage>&#x02013;<lpage>334</lpage>. <pub-id pub-id-type="pmid">11466099</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>de Lemos</surname><given-names>ET</given-names></name><name><surname>Oliveira</surname><given-names>J</given-names></name><name><surname>Pinheiro</surname><given-names>JP</given-names></name><etal>et al.</etal></person-group>: <article-title>Regular physical exercise as a strategy to improve
antioxidant and anti-inflammatory status: benefits in type 2 diabetes
mellitus</article-title>. <source>Oxid Med Cell Longev</source>, <year>2012</year>,
<volume>2012</volume>: <fpage>741545</fpage>. <pub-id pub-id-type="pmid">22928086</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Brandt</surname><given-names>C</given-names></name><name><surname>Pedersen</surname><given-names>BK</given-names></name></person-group>: <article-title>The role of exercise-induced myokines in muscle
homeostasis and the defense against chronic diseases</article-title>. <source>J Biomed
Biotechnol</source>, <year>2010</year>, <volume>2010</volume>: <fpage>520258</fpage>.
<pub-id pub-id-type="pmid">20224659</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Wellen</surname><given-names>KE</given-names></name><name><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group>: <article-title>Inflammation, stress, and diabetes</article-title>.
<source>J Clin Invest</source>, <year>2005</year>, <volume>115</volume>:
<fpage>1111</fpage>&#x02013;<lpage>1119</lpage>. <pub-id pub-id-type="pmid">15864338</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Petersen</surname><given-names>AM</given-names></name><name><surname>Pedersen</surname><given-names>BK</given-names></name></person-group>: <article-title>The anti-inflammatory effect of exercise</article-title>.
<source>J Appl Physiol 1985</source>, <year>2005</year>, <volume>98</volume>:
<fpage>1154</fpage>&#x02013;<lpage>1162</lpage>. <pub-id pub-id-type="pmid">15772055</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Jae</surname><given-names>SY</given-names></name><name><surname>Fernhall</surname><given-names>B</given-names></name><name><surname>Heffernan</surname><given-names>KS</given-names></name><etal>et al.</etal></person-group>: <article-title>Effects of lifestyle modifications on C-reactive protein:
contribution of weight loss and improved aerobic capacity</article-title>.
<source>Metabolism</source>, <year>2006</year>, <volume>55</volume>:
<fpage>825</fpage>&#x02013;<lpage>831</lpage>. <pub-id pub-id-type="pmid">16713444</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Beavers</surname><given-names>KM</given-names></name><name><surname>Brinkley</surname><given-names>TE</given-names></name><name><surname>Nicklas</surname><given-names>BJ</given-names></name></person-group>: <article-title>Effect of exercise training on chronic
inflammation</article-title>. <source>Clin Chim Acta</source>, <year>2010</year>,
<volume>411</volume>: <fpage>785</fpage>&#x02013;<lpage>793</lpage>. <pub-id pub-id-type="pmid">20188719</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Amy</surname><given-names>EM</given-names></name><name><surname>Rob</surname><given-names>D</given-names></name><name><surname>Frank</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>A 12-week sports-based exercise programme for inactive
Indigenous Australian men improved clinical risk factors associated with type 2 diabetes
mellitus</article-title>. <source>J Sci Med Sport</source>, <year>2014</year>,
<volume>06</volume>: <fpage>1052</fpage>&#x02013;<lpage>1057</lpage>.</mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Kim</surname><given-names>DY</given-names></name><name><surname>Seo</surname><given-names>BD</given-names></name><name><surname>Kim</surname><given-names>DJ</given-names></name></person-group>: <article-title>Effect of walking exercise on changes in cardiorespiratory
fitness, metabolic syndrome markers, and high-molecular-weight Adiponectin in obese
middle-aged women</article-title>. <source>J Phys Ther Sci</source>, <year>2014</year>,
<volume>26</volume>: <fpage>1723</fpage>&#x02013;<lpage>1727</lpage>. <pub-id pub-id-type="pmid">25435686</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Balducci</surname><given-names>S</given-names></name><name><surname>Zanuso</surname><given-names>S</given-names></name><name><surname>Nicolucci</surname><given-names>A</given-names></name><etal>et al.</etal></person-group>: <article-title>Anti-inflammatory effect of exercise training in subjects
with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and
independent of weight loss</article-title>. <source>Nutr Metab Cardiovasc Dis</source>,
<year>2010</year>, <volume>20</volume>: <fpage>608</fpage>&#x02013;<lpage>617</lpage>.
<pub-id pub-id-type="pmid">19695853</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Bouloumi&#x000e9;</surname><given-names>A</given-names></name><name><surname>Curat</surname><given-names>CA</given-names></name><name><surname>Sengen&#x000e8;s</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Role of macrophage tissue infiltration in metabolic
diseases</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>,
<year>2005</year>, <volume>8</volume>: <fpage>347</fpage>&#x02013;<lpage>354</lpage>.
<pub-id pub-id-type="pmid">15930956</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group><name><surname>Romzova</surname><given-names>M</given-names></name><name><surname>Hohenadel</surname><given-names>D</given-names></name><name><surname>Kolostova</surname><given-names>K</given-names></name><etal>et al.</etal></person-group>: <article-title>NFkappaB and its inhibitor IkappaB in relation to type 2
diabetes and its microvascular and atherosclerotic complications</article-title>.
<source>Hum Immunol</source>, <year>2006</year>, <volume>67</volume>:
<fpage>706</fpage>&#x02013;<lpage>713</lpage>. <pub-id pub-id-type="pmid">17002901</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Borg</surname><given-names>GA</given-names></name></person-group>: <article-title>Psychophysical bases of perceived
exertion</article-title>. <source>Med Sci Sports Exerc</source>, <year>1982</year>,
<volume>14</volume>: <fpage>377</fpage>&#x02013;<lpage>381</lpage>. <pub-id pub-id-type="pmid">7154893</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Pollock</surname><given-names>ML</given-names></name><name><surname>Broida</surname><given-names>J</given-names></name><name><surname>Kendrick</surname><given-names>Z</given-names></name></person-group>: <article-title>Validity of the palpation technique of heart rate
determination and its estimation of training heart rate</article-title>. <source>Res
Q</source>, <year>1972</year>, <volume>43</volume>: <fpage>77</fpage>&#x02013;<lpage>81</lpage>.
<pub-id pub-id-type="pmid">4503118</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Koltyn</surname><given-names>KF</given-names></name><name><surname>Morgan</surname><given-names>WP</given-names></name></person-group>: <article-title>Efficacy of perceptual versus heart rate monitoring in the
development of endurance</article-title>. <source>Br J Sports Med</source>,
<year>1992</year>, <volume>26</volume>: <fpage>132</fpage>&#x02013;<lpage>134</lpage>.
<pub-id pub-id-type="pmid">1623360</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Williams</surname><given-names>MA</given-names></name><name><surname>Haskell</surname><given-names>WL</given-names></name><name><surname>Ades</surname><given-names>PA</given-names></name><etal>et al.</etal></person-group>American Heart Association Council on Clinical CardiologyAmerican Heart
Association Council on Nutrition, Physical Activity, and Metabolism:
<article-title>Resistance exercise in individuals with and without cardiovascular
disease: 2007 update: a scientific statement from the American Heart Association Council
on Clinical Cardiology and Council on Nutrition, Physical Activity, and
Metabolism</article-title>. <source>Circulation</source>, <year>2007</year>,
<volume>116</volume>: <fpage>572</fpage>&#x02013;<lpage>584</lpage>. <pub-id pub-id-type="pmid">17638929</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Wu</surname><given-names>YT</given-names></name><name><surname>Hwang</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>CN</given-names></name><etal>et al.</etal></person-group>: <article-title>Home-based exercise for middle-aged Chinese at diabetic
risk: a randomized controlled trial</article-title>. <source>Prev Med</source>,
<year>2011</year>, <volume>52</volume>: <fpage>337</fpage>&#x02013;<lpage>343</lpage>.
<pub-id pub-id-type="pmid">21371496</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Bonora</surname><given-names>E</given-names></name><name><surname>Targher</surname><given-names>G</given-names></name><name><surname>Alberiche</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>Homeostasis model assessment closely mirrors the glucose
clamp technique in the assessment of insulin sensitivity: studies in subjects with
various degrees of glucose tolerance and insulin sensitivity</article-title>.
<source>Diabetes Care</source>, <year>2000</year>, <volume>23</volume>:
<fpage>57</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="pmid">10857969</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Heo</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>E</given-names></name></person-group>: <article-title>Effects of endurance training on lipid metabolism and
glycosylated hemoglobin levels in Streptozotocin-induced type 2 diabetic rats on a
high-fat diet</article-title>. <source>J Phys Ther Sci</source>, <year>2013</year>,
<volume>25</volume>: <fpage>989</fpage>&#x02013;<lpage>992</lpage>. <pub-id pub-id-type="pmid">24259900</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Dengel</surname><given-names>DR</given-names></name><name><surname>Pratley</surname><given-names>RE</given-names></name><name><surname>Hagberg</surname><given-names>JM</given-names></name><etal>et al.</etal></person-group>: <article-title>Distinct effects of aerobic exercise training and weight
loss on glucose homeostasis in obese sedentary men</article-title>. <source>J Appl
Physiol 1985</source>, <year>1996</year>, <volume>81</volume>:
<fpage>318</fpage>&#x02013;<lpage>325</lpage>. <pub-id pub-id-type="pmid">8828680</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal">Tamura T, KidA K, Seki T, et
al.: <article-title>Study of the relationship between exercise therapy and diet therapy in
type 2 diabetes mellitus patients</article-title>. <source>J Phys Ther Sci</source>,
<year>2011</year>, <volume>23</volume>: <fpage>485</fpage>&#x02013;<lpage>488</lpage>.
</mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Lucha-L&#x000f3;pez</surname><given-names>MO</given-names></name><name><surname>Lucha-L&#x000f3;pez</surname><given-names>AC</given-names></name><name><surname>Vidal-Peracho</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Study of the relationship between exercise therapy and
diet therapy in type 2 diabetes mellitus patients</article-title>. <source>J Phys Ther
Sci</source>, <year>2012</year>, <volume>24</volume>:
<fpage>1299</fpage>&#x02013;<lpage>1305</lpage>.</mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Krousel-Wood</surname><given-names>MA</given-names></name><name><surname>Berger</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><etal>et al.</etal></person-group>: <article-title>Does home-based exercise improve body mass index in
patients with type 2 diabetes? Results of a feasibility trial</article-title>.
<source>Diabetes Res Clin Pract</source>, <year>2008</year>, <volume>79</volume>:
<fpage>230</fpage>&#x02013;<lpage>236</lpage>. <pub-id pub-id-type="pmid">17942181</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Ferrer-Garc&#x000ed;a</surname><given-names>JC</given-names></name><name><surname>S&#x000e1;nchez L&#x000f3;pez</surname><given-names>P</given-names></name><name><surname>Pablos-Abella</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>[Benefits of a home-based physical exercise program in
elderly subjects with type 2 diabetes mellitus]</article-title>. <source>Endocrinol
Nutr</source>, <year>2011</year>, <volume>58</volume>:
<fpage>387</fpage>&#x02013;<lpage>394</lpage>. <pub-id pub-id-type="pmid">21816692</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>Rathcke</surname><given-names>CN</given-names></name><name><surname>Johansen</surname><given-names>JS</given-names></name><name><surname>Vestergaard</surname><given-names>H</given-names></name></person-group>: <article-title>YKL-40, a biomarker of inflammation, is elevated in
patients with type 2 diabetes and is related to insulin resistance</article-title>.
<source>Inflamm Res</source>, <year>2006</year>, <volume>55</volume>:
<fpage>53</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="pmid">16612564</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Tokmakidis</surname><given-names>SP</given-names></name><name><surname>Touvra</surname><given-names>AM</given-names></name><name><surname>Douda</surname><given-names>HT</given-names></name><etal>et al.</etal></person-group>: <article-title>Training, detraining, and retraining effects on glycemic
control and physical fitness in women with type 2 diabetes</article-title>. <source>Horm
Metab Res</source>, <year>2014</year>, <volume>46</volume>:
<fpage>974</fpage>&#x02013;<lpage>979</lpage>. <pub-id pub-id-type="pmid">25369073</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group><name><surname>Dasu</surname><given-names>MR</given-names></name><name><surname>Devaraj</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><etal>et al.</etal></person-group>: <article-title>Increased toll-like receptor (TLR) activation and TLR
ligands in recently diagnosed type 2 diabetic subjects</article-title>. <source>Diabetes
Care</source>, <year>2010</year>, <volume>33</volume>:
<fpage>861</fpage>&#x02013;<lpage>868</lpage>. <pub-id pub-id-type="pmid">20067962</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group><name><surname>Jialal</surname><given-names>I</given-names></name><name><surname>Huet</surname><given-names>BA</given-names></name><name><surname>Kaur</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>: <article-title>Increased toll-like receptor activity in patients with
metabolic syndrome</article-title>. <source>Diabetes Care</source>, <year>2012</year>,
<volume>35</volume>: <fpage>900</fpage>&#x02013;<lpage>904</lpage>. <pub-id pub-id-type="pmid">22357188</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group><name><surname>Adaikalakoteswari</surname><given-names>A</given-names></name><name><surname>Rema</surname><given-names>M</given-names></name><name><surname>Mohan</surname><given-names>V</given-names></name><etal>et al.</etal></person-group>: <article-title>Oxidative DNA damage and augmentation of poly(ADP-ribose)
polymerase/nuclear factor-kappa B signaling in patients with type 2 diabetes and
microangiopathy</article-title>. <source>Int J Biochem Cell Biol</source>,
<year>2007</year>, <volume>39</volume>: <fpage>1673</fpage>&#x02013;<lpage>1684</lpage>.
<pub-id pub-id-type="pmid">17540609</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group><name><surname>Gracie</surname><given-names>JA</given-names></name><name><surname>Robertson</surname><given-names>SE</given-names></name><name><surname>McInnes</surname><given-names>IB</given-names></name></person-group>: <article-title>Interleukin-18</article-title>. <source>J Leukoc
Biol</source>, <year>2003</year>, <volume>73</volume>:
<fpage>213</fpage>&#x02013;<lpage>224</lpage>. <pub-id pub-id-type="pmid">12554798</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group><name><surname>Moriwaki</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Shibutani</surname><given-names>Y</given-names></name><etal>et al.</etal></person-group>: <article-title>Elevated levels of interleukin-18 and tumor necrosis
factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with
diabetic nephropathy</article-title>. <source>Metabolism</source>, <year>2003</year>,
<volume>52</volume>: <fpage>605</fpage>&#x02013;<lpage>608</lpage>. <pub-id pub-id-type="pmid">12759891</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group><name><surname>Thorand</surname><given-names>B</given-names></name><name><surname>Kolb</surname><given-names>H</given-names></name><name><surname>Baumert</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>: <article-title>Elevated levels of interleukin-18 predict the development
of type 2 diabetes: results from the MONICA/KORA Augsburg Study,
1984</article-title>&#x02013;<article-title>2002</article-title>. <source>Diabetes</source>,
<year>2005</year>, <volume>54</volume>: <fpage>2932</fpage>&#x02013;<lpage>2938</lpage>.
</mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group><name><surname>Miller</surname><given-names>AM</given-names></name><name><surname>Liew</surname><given-names>FY</given-names></name></person-group>: <article-title>The IL-33/ST2 pathway&#x02014;a new therapeutic target in
cardiovascular disease</article-title>. <source>Pharmacol Ther</source>,
<year>2011</year>, <volume>131</volume>: <fpage>179</fpage>&#x02013;<lpage>186</lpage>.
<pub-id pub-id-type="pmid">21356240</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group><name><surname>Miller</surname><given-names>AM</given-names></name><name><surname>Asquith</surname><given-names>DL</given-names></name><name><surname>Hueber</surname><given-names>AJ</given-names></name><etal>et al.</etal></person-group>: <article-title>Interleukin-33 induces protective effects in adipose
tissue inflammation during obesity in mice</article-title>. <source>Circ Res</source>,
<year>2010</year>, <volume>107</volume>: <fpage>650</fpage>&#x02013;<lpage>658</lpage>.
<pub-id pub-id-type="pmid">20634488</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group><name><surname>Milovanovic</surname><given-names>M</given-names></name><name><surname>Volarevic</surname><given-names>V</given-names></name><name><surname>Radosavljevic</surname><given-names>G</given-names></name><etal>et al.</etal></person-group>: <article-title>IL-33/ST2 axis in inflammation and
immunopathology</article-title>. <source>Immunol Res</source>, <year>2012</year>,
<volume>52</volume>: <fpage>89</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="pmid">22392053</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group><name><surname>Yang</surname><given-names>HS</given-names></name><name><surname>Woo</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><etal>et al.</etal></person-group>: <article-title>Elevated plasma pentraxin 3 levels are associated with
development and progression of diabetic retinopathy in Korean patients with type 2
diabetes mellitus</article-title>. <source>Invest Ophthalmol Vis Sci</source>,
<year>2014</year>, <volume>55</volume>: <fpage>5989</fpage>&#x02013;<lpage>5997</lpage>.
<pub-id pub-id-type="pmid">25159210</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group><name><surname>Hempen</surname><given-names>M</given-names></name><name><surname>Kopp</surname><given-names>HP</given-names></name><name><surname>Elhenicky</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>YKL-40 is elevated in morbidly obese patients and declines
after weight loss</article-title>. <source>Obes Surg</source>, <year>2009</year>,
<volume>19</volume>: <fpage>1557</fpage>&#x02013;<lpage>1563</lpage>. <pub-id pub-id-type="pmid">19633900</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group><name><surname>Bai</surname><given-names>HP</given-names></name><name><surname>Gao</surname><given-names>QJ</given-names></name></person-group>: <article-title>Effects of swimming exercise on inflammation and oxidative
stress status in diabetic mellitus type2 rats</article-title>. <source>Chin J Rehabilit
Med</source>, <year>2013</year>, <volume>28</volume>:
<fpage>708</fpage>&#x02013;<lpage>713</lpage>.</mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group><name><surname>Di Raimondo</surname><given-names>D</given-names></name><name><surname>Tuttolomondo</surname><given-names>A</given-names></name><name><surname>Butt&#x000e0;</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Metabolic and anti-inflammatory effects of a home-based
programme of aerobic physical exercise</article-title>. <source>Int J Clin
Pract</source>, <year>2013</year>, <volume>67</volume>:
<fpage>1247</fpage>&#x02013;<lpage>1253</lpage>. <pub-id pub-id-type="pmid">24246205</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group><name><surname>do Nascimento</surname><given-names>ES</given-names></name><name><surname>Sampaio</surname><given-names>LM</given-names></name><name><surname>Peixoto-Souza</surname><given-names>FS</given-names></name><etal>et al.</etal></person-group>: <article-title>Home-based pulmonary rehabilitation improves clinical
features and systemic inflammation in chronic obstructive pulmonary disease
patients</article-title>. <source>Int J Chron Obstruct Pulmon Dis</source>,
<year>2015</year>, <volume>10</volume>: <fpage>645</fpage>&#x02013;<lpage>653</lpage>.
<pub-id pub-id-type="pmid">25848241</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group><name><surname>Nickel</surname><given-names>T</given-names></name><name><surname>Emslander</surname><given-names>I</given-names></name><name><surname>Sisic</surname><given-names>Z</given-names></name><etal>et al.</etal></person-group>: <article-title>Modulation of dendritic cells and toll-like receptors by
marathon running</article-title>. <source>Eur J Appl Physiol</source>,
<year>2012</year>, <volume>112</volume>: <fpage>1699</fpage>&#x02013;<lpage>1708</lpage>.
<pub-id pub-id-type="pmid">21881949</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group><name><surname>McFarlin</surname><given-names>BK</given-names></name><name><surname>Flynn</surname><given-names>MG</given-names></name><name><surname>Campbell</surname><given-names>WW</given-names></name><etal>et al.</etal></person-group>: <article-title>Physical activity status, but not age, influences
inflammatory biomarkers and toll-like receptor 4</article-title>. <source>J Gerontol A
Biol Sci Med Sci</source>, <year>2006</year>, <volume>61</volume>:
<fpage>388</fpage>&#x02013;<lpage>393</lpage>. <pub-id pub-id-type="pmid">16611706</pub-id></mixed-citation></ref><ref id="r44"><label>44</label><mixed-citation publication-type="journal"><person-group><name><surname>Lambert</surname><given-names>CP</given-names></name><name><surname>Wright</surname><given-names>NR</given-names></name><name><surname>Finck</surname><given-names>BN</given-names></name><etal>et al.</etal></person-group>: <article-title>Exercise but not diet-induced weight loss decreases
skeletal muscle inflammatory gene expression in frail obese elderly
persons</article-title>. <source>J Appl Physiol 1985</source>, <year>2008</year>,
<volume>105</volume>: <fpage>473</fpage>&#x02013;<lpage>478</lpage>. <pub-id pub-id-type="pmid">18535122</pub-id></mixed-citation></ref><ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group><name><surname>Kohut</surname><given-names>ML</given-names></name><name><surname>McCann</surname><given-names>DA</given-names></name><name><surname>Russell</surname><given-names>DW</given-names></name><etal>et al.</etal></person-group>: <article-title>Aerobic exercise, but not flexibility/resistance exercise,
reduces serum IL-18, CRP, and IL-6 independent of beta-blockers, BMI, and psychosocial
factors in older adults</article-title>. <source>Brain Behav Immun</source>,
<year>2006</year>, <volume>20</volume>: <fpage>201</fpage>&#x02013;<lpage>209</lpage>.
<pub-id pub-id-type="pmid">16504463</pub-id></mixed-citation></ref><ref id="r46"><label>46</label><mixed-citation publication-type="journal"><person-group><name><surname>Tr&#x000f8;seid</surname><given-names>M</given-names></name><name><surname>Lappeg&#x000e5;rd</surname><given-names>KT</given-names></name><name><surname>Mollnes</surname><given-names>TE</given-names></name><etal>et al.</etal></person-group>: <article-title>The effect of exercise on serum levels of interleukin-18
and components of the metabolic syndrome</article-title>. <source>Metab Syndr Relat
Disord</source>, <year>2009</year>, <volume>7</volume>:
<fpage>579</fpage>&#x02013;<lpage>584</lpage>. <pub-id pub-id-type="pmid">19900154</pub-id></mixed-citation></ref></ref-list></back></article>